Literature

YearAuthorsTitleCategory
2004Suovaniemi O.Automated Instrumentation for reserach and clinical laboratories, Academic dissertation, 2004Vertical Photometry
2019Suumann J, Sillakivi T, Riispere Ž, Syrjänen K, Sipponen P, Kirsimägi Ü , Peetsalu ASerum Gastric Biomarker Levels After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Operations: A Prospective Study with 1-year Follow-up, Surg. Gastroenterol. Oncol. 2019;24(2):86-94GastroPanel
2016Goni E, Link A, Langner C, Venerito M, Malfertheiner P.Impact of preanalytical factors on stability of pepsinogen I, II and gastrin 17. Helicobacter 2016; 21(Suppl 1):99 (P01.17)GastroPanel
2016Kayamba VJ, Aaron S, Zyambo K, Morgan D, Heimburger D, Banda T, Kelly P.Use of Anti-Retroviral Therapy Has No Influence on the Occurrence of Gastric Premalignant Lesions in HIV Infected Zambian Adults. DDW 2016 poster presentation Tu1287GastroPanel
2016Krike P, Shums Z, Rudzite D, Isajevs S, Polaka I, Norman GL, Leja M.The prevalence of anti-parietal cell and anti-intrinsic factor antibodies, pepsinogens, gastrin-17 and H.pylori infection in corpus-restricted gastritis patients Helicobacter 2016; 21(suppl 1):161-162 (P09.02)GastroPanel
2016Lee YC, Chiang TH, Chou CK, Chiu HM, Wu MS. Serological Biomarkers for Gastric Cancer Screening in a Population That Has Undergone Mass Eradication of Helicobacter pylori. DDW 2016 poster presentation Su1035.GastroPanel
2016Lee YC, Chou CK, Chiang TH, Chiu HM, Wu MS.The Association Between Serum Pepsinogen Testing and Death From Gastric Cancer: A Sixteen-Year Population-Based Cohort Study. DDW 2016 poster presentation Su1034.Pepsinogen
2016Marchesi F, Ricco M, Tartamella F, Forlini C, De Sario G, Rizzi N, Caleffi A, Di Mario F.Helicobacter pylori in severe obese patients undergoing roux-en-y gastric bypass: non-invasive follow-up and eradication therapy. Helicobacter 2016; 21(Suppl 1):138 (P07.03).GastroPanel
2016Skrebinska S, Santare D, Isajevs S, Liepniece-Karele I, Rudzite D, Kikuste I, Vanags A, Tolmanis I, Atstupens J, Murillo R, Park JY, Herrero R, Daugule I, Leja M.Helicobacter 2016;21(Suppl 1):97 (P01.12).Helicobacter
2016Wang X, Bin L, Hu Y, Zhang M, Chen C.Gastric Cancer Screening by Combined Serum Pepsinogen Levels and Gastritis Staging in China. DDW 2016 poster presentation Su 1050.Pepsinogen
2016Urke A, Krike P, Shums Z, Rudzite D, Polaka I, Sivins A, Jelovskis I, Isajevs S, Bogdanova I, Boka V, Vikmanis U, Norman GL, Leja M.The prevalence of anti-parietal cell and intrinsic factor antibodies in patients with gastric adenocarcinoma.Helicobacter 2016; 21(suppl 1): 130-131 (P06.10)GastroPanel
2015Goni E, Riccò M, Franceschi M, Baldassarre G, Panozzo MP, Antico A, De Bastiani R, Scarpignato C, Di Mario F. GASTRIN 17 AS NON INVASIVE MARKER OF REFLUX DISEASE. UEGW 2015 Poster presentation P1740.GastroPanel
2010Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, Basso D, Plebani M, Graham DY.Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010; 31(10):1104-11. doi: 10.1111/j.1365-2036.2010.04277.GastroPanel
2009Reshetnikov OV, Kurilovich SA, Bobak M, Maliutina SK, Pylenkova EDGastrointestinal symptoms in adult population of Novosibirsk city: prevalence and risk factors. Ter Arkh. 2009;81(2):11-6. [Article in Russian].GastroPanel
2015Franceschi M, Massella A, Panozzo M, Baldassarre G, Sella D, Antico A, Cerofolini A, Goni E, Di Mario F. GastroPanel serum markers as a non-invasive method for the diagnosis of H. pylori-related Gastritis. Poster presentation P01.01 at European Helicobacter Study Group 2015 congress. Helicobacter 2015:20(Suppl. 1); 86.GastroPanel
2009Guariso G, Basso D, Bortoluzzi CF, Meneghel A, Schiavon S, Fogar P, Farina M, Navaglia F, Greco E, Mescoli C, Zambon CF, Plebani M. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. Clin Chim Acta 2009 Apr;402(1-2):54-60.GastroPanel
2014Masci E, Pellicano R, Mangiavillano B, Luigiano C, Stelitano L, Morace C, Viale E, Freschi M, Locatelli M, Ieri R, Cavallaro A, Testoni S, Testoni PA. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia. Minerva Gastroenterol Dietol. 2014 Mar;60(1):79-83.GastroPanel
2012Zhang Y, Sun L_P, Xing C-Z, Xu Q, He CY, Li P, Gong Y-H, Liu Y-P, Yuan YInteraction between GSTP1 Val Allele and H. pylori Infection, Smoking and Alcohol Consumption and Risk of Gastric Cancer among the Chinese Population. PLoS ONE 7(10): e47178.15.10.2012Helicobacter pylori igG
2012Salaspuro M. Interactions of alcohol and tobacco in gastrointestinal cancer. J Gastroenterol Hepatol 2012; 27 (Suppl 2): 135 -139.Acetaldehyde
2009Kim N, Eshmuratov A, Nah JC The correlation of Endoscopic and Histological Diagnosis of Gastric Atrophy. DDW 2009; T1074 Gastroenterol 2009; 136(5): A-732 (W1820)GastroPanel
2011Attumi TA, Graham DY. Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations. Clin Gastroenterol Hepatol 2011; 9:373-375.Helicobacter pylori infection
2014Di Mario F, Goni EGastric acid secretion: Changes during a century. Best Pract Res Clin Gastroenterol. 2014; 28(6):953-965.Gastric disease
2013Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H.Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev 2013; 5:821-826. DOI: 10.1158/1055-9965.EPI-12-1343GastroPanel
2009Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis?Scand J Gastroenterol. 2010;45(2):133-138GastroPanel
2009Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner HAlcohol consumption and chronic atrophic gastritis: Population-based study among 9,444 older adults from Germany Int J Cancer 2009; 125:2918–2922.Gastric disease
2009Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa TSerum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.World J Gastroenterol 2009;15(7):853-859GastroPanel
2009Ren JS, Kamangar F, Qiao YL, Taylor P, Liang H, Dawsey S, Liu B, Fan JH, Abnet C.Serum pepsinogens and risk of gastric and esophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 2009; 58:636-642Pepsinogen
2008Sun LP, Gong YH, Wang L, Gong W, Yuan YFollow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay J Dig Dis. 2008 Feb;9(1):20-6GastroPanel
2008Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Bessonov PP, Vasil'ev RR, Tatarinova OV, Muchina EGPrevalence of atrophic gastritis in different populations in Siberia on medical evidence of the serological survey. Klin Med (Mosk). 2008;86(7):35-8.GastroPanel
2007Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EVHelicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogenII levels in patients with duodenal ulcer. J Gastroenterol Hepatol 2008; 23: 1666-1671.GastroPanel
2007Sun LP, Gong YH, Wang L, Yuan YSerum pepsinogen levels and their influencing factors: A population-based study in 6990 Chinese from North China. World J Gastroenterol 2007 December 28; 13(48): 6562-6567GastroPanel
2011Salaspuro M. Acetaldehyde and gastric cancer. J Dig Dis 2011; 12: 51–59.Acetaldehyde
2009Salaspuro M. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scan J Gastroenterol 2009; 44:912-925.Acetaldehyde
2013 Ahn JS, Eom CS, Jeon CY, Park SMAcid suppressive drugs and gastric cancer: A meta-analysis of observational studies. World J Gastroenterol 2013;19(16): 2560-2568.Gastric disease PPI
2007Koivusalo AI, Pakarinen MP, Kolho KLIs GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children? Diagn Microbiol Infect Dis. 2007 Jan;57(1):35-8. Epub 2006 Sep 1GastroPanel
2006Halliday JCysteine gum may reduce tobacco, alcohol cancer risk. Published online www.nutraingredients.com, 29 May 2006 20.9.2006Acetaldehyde
2006Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko METime course changes inmorphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers. Ter Arkh. 2006; 78(2):26-31. [Article in Russian].GastroPanel
2004Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes World J Gastroenterol 2004;10(21):3146-3150GastroPanel
2009de Vries AC, van Driel HF, Richardus JH, Ouwendijk M, van Vuuren AJ, de Man RA, Kuipers EJMigrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. Scand J Gastroenterol. 2008;43(4):403-9.Pepsinogens
2008Pimanov SI, Makarenko EVPotentialities of a serological method in diagnosis of atrophic gastritis. Ter Arkh 2008: 80(2); 15-21. [Article in Russian]GastroPanel
2009Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M and Agréus LSerum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008; 43:1448-1455.GastroPanel
2007Parthasarathy G, Maroju NK, Kate V, Ananthakrishnan N, Sridhar MG. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach. Trop Gastroenterol 2007; 28(4):166-70.GastroPanel
2013Furnari M, Bonfanti D, Parodi A, Franzè J, Savarino E, Bruzzone L, Moscatelli A, Di Mario F, Dulbecco P, Savarino V.A comparison between lactose breath test and quick test on duodenal biopsies for diagnosing lactase deficiency in patients with self-reported lactose intolerance. J Clin Gastroenterol 2013;47:148–152. doi: 10.1097/MCG.0b013e31824e9132Lactose Intolerance
2006Salaspuro V, Hietala J, Marvola M, Salaspuro MEliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epidemiol Biomarkers Prev 2006;15:146-149.Acetaldehyde
2017Lachenmeier DW, Salaspuro M.ALDH2-deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde. Regulatory Toxicology and Pharmacology 2017. Regulatory Toxicology and Pharmacology 86 (2017) 128e136.Acetaldehyde
2006Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L, Chavez A, Cardenas VNoninvasive Versus Histologic Detection of Gastric Atrophy an Hispanic Population in North America. Clin Gastroenterol Hepatol 2006; 4:306-314.GastroPanel
2006Kuokkanen M, Myllyniemi M, Vauhkonen M, Kääriäinen I, Karesvuori S, Linnala A, Härkönen M, Järvelä I, Sipponen PA biops-based guick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy 2006;38(7):708-712. Lactose Intolerance
2009Goetze JP, Paloheimo LI, Linnala A, Sipponen P, Palnœs Hansen C, Rehfeld JFShort report. Gastrin-17 specific antibodies are too specific for gastrinoma diagnosis but stain G-cells. Scand J Gastroenterol 2005; 40:596-598.Gastric disease
2005Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, De Rosa G, Budillon. GDiagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther 2005; 22:1139–1146.GastroPanel
2013Ebule IA, Longdoh AN, Paloheimo LIHelicobacter pylori infection and atrophic gastritis. African Health Sciences 2013; 13(1): 12 – 117.GastroPanel
2010Redéen S, Ryberg A, Petersson F, Eriksson O, Nägga K, Borch KHomocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia. Dig Dis Sci 2010; 55(2):351-8.GastroPanel
2004Di Mario F, Moussa AM, Cavallaro LG, Caruana P, Merli R, Bertolini S, Iori V, Cavestro GM, Dal Bò N, Pilotto A, Franzé A, Leandro GClinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Digestion 2004; 70:167-172.Pepsinogen II
2004Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Boldys H, Romanczyk TNon-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastro-Enterologica Belgica 2004; Vol. LXVII:320-326.GastroPanel
2003Broutet N, Plebani M, Sakarovitch C, Sipponen P, Mégraud FEurohepygast Study Group. Pepsinogen A, Pepsinogen C, and Gastrin as Makers of Atrophic Chronic Gastritis in European Dyspeptics. British Journal of Cancer 2003; 88: 1239-1247.GastroPanel
2003Gøtze JP, Rehfeldt JFImpact of Assay Epitope Specificity in Gastrinoma Diagnosis. Clin Chem 2003; 49 No 2: 333-4.Gastric disease
2003Konturek SJ, Konturek PC, Bielanski W, Karczewska E, Zuchowicz M, Hartwich A, Rehfeld JF, Goetze JP, Hahn EGSerum Progastrin and Its Products, Gastric Acid Secretion and Serum Pepsinogen I in Gastric Cancer. Digestion 2003; 68:169-177.Gastric disease
2003Kuipers EJIn through the Out Door: Serology for Atrophic Gastritis, European Journal of Gastroenterology & Hepatology 2003; 15: 877-879.GastroPanel
2003Sipponen P, Härkönen M, Alanko A, Suovaniemi ODiagnosis of Atrophic Gastritis from a Serum Sample. Minerva Gastroenterol Dietol 2003; 49: 11-21.GastroPanel
2003Sipponen P, Laxen F, Huotari K, Härkönen M.Prevalence of Low Vitamin B-12 and High Homocysteine in Serum in an Elderly Male Population. Associociation with Atrophic Gastritis and H.pylori Infection. Scand J Gastroenterol 2003; Vol 38 (12): 1209-1216.Gastric disease
2003Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M, Jussila A, Sipponen P.Non-Endoscopic Diagnosis of Atrophic Gastritis with a Blood Test. Correlation between Gastric Histology and Serum Levels of Gastrin-17 and Pepsinogen I. A Multicenter Study. Eur J Gastroenterol Hepatol 2003; 15: 885-891.GastroPanel
2002Sipponen PGastric Cancer. Pathogenesis, Risks, and Prevention. J Gastroenterol 2002; 37 (Suppl XIII): 39-44.Gastric disease
2002Sipponen P, Härkönen M, Alanko A, Suovaniemi O Diagnosis of Atrophic Gastritis from a Serum Sample. Clin Lab 2002; 48:505-515.GastroPanel
2002Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.Serum levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control Study. Scand J Gastroenterol 2002; 37: 785-791.Gastric disease
2001Sande N, Nikulin M, Nilsson I, Wadström T, Laxen F, Härkönen M, Suovaniemi O, Sipponen PIncreased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001; 36:928-933.GastroPanel
2001Sipponen P.Clinical Reviews. New Techniques. Update on the Pathologic Approach to the Diagnosis of Gastritis, Gastric Atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001; 32(3):196-202.GastroPanel
2011Linderborg K, Salaspuro M, Väkeväinen S. A single sip of a strong alcoholic beverage causes exposure to carcinogenic concentrations of acetaldehyde in the oral cavity. Food Chem Toxicol. 2011; 49(9):2103-6.Acetaldehyde
2004Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, Wang X, Wang BL, Miao JY, Ding J, Fan DM.Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Dig Dis 2004;5(1):22-27GastroPanel
2003Salaspuro MP. Alcohol consumption and cancer of the gastrointestinal tract. Best practice & Research Clinical Gastroenterology 2003; 17(4):679-674.acetaldehyde
2007Valle Mu?os J, Varasa TA, Pardo RL, Merlo RR, Grueso MJP, Escobedo RM, Torres MA, Boy RC, Jimenez JMC.Diagnóstico serológico de gastritis atrófica con una combibación de pepsinógeno I y II, gastrina-17 y anticuerpos anti-Helicobacter pylori. Gastroenterol Hepatol 2007; 30(10):567-571.GastroPanel
2007Weck MN, Stegmaier C, Rothenbacher D, Brenner HEpidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 2007; 26:879–887Pepsinogens
2009Sipponen P, Graham DYImportance of atrophic gastritis in diagnostics and prevention of gastric cancer: Application of plasma biomarkers. Scand J Gastroenterol 2007; 42:2-10.GastroPanel
2006van Oijen MGH, Vlemmix F, Laheij RJF, Paloheimo L, Jansen JBMJ, Verheugt FWA. Hyperhomocysteinaemia and Vitamin B12 Deficiency: The Long-Term Effects in Cardiovascular Disease. Cardiology 2007;107: 57-62.GastroPanel
2010 Telaranta-Keerie A, Kara R, Paloheimo L, Härkönen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4256 volunteers without specific complaints. Scand J Gastroenterol 2010; 45:1036-1041.GastroPanel
2009Jolanda F, Parodi A, Savarino E, Morana E, Bertelè A, Savarino V, Di Mario FComparison Between Lactose Breath Test and a Quick Test On Duodenal Biopsies for Lactase Deficiency, in Patients with a Self Reported Lactose Intolerance. Gastroenterology 2009; 136(5): A-323 (S2067).Lactose Intolerance
2012Rao P, Rao N, Jordinson M, Scott C, Hinchcliffe C, Campbell D. Comparison of quick point of care test for small bowel hypolactasia with biochemical lactase assay in children. J Pediatr Gastroenterol Nutr. 2012; 54 (3):401-403.Lactose Intolerance
2017Maejima R, Iijima K, Kaihovaara P, Hatta W, Koike T, Imatani A, Shimisegawa T, Salaspuro M. Effects of ALDH2 Genotype, PPI Treatment and L-Cysteine on Carcinogenic Acetaldehyde in Gastric Juice and Saliva after Intragastric Alcohol Administration. PLOS ONE 1.4.2015; PLOS ONE | DOI:10.1371/journal.pone.0120397.Acetaldehyde
2017Tursi A, De Bastiani R, Franceschi ML, Goni E, Riccò M, Venerito M, Rugge M, Scarpignato C, Picchio M, Di Mario F, the Primary Care collaborative group.Non-invasive assessment of gastric secretory function in centenarians. Geriatric Care 2017; 3:6682.GastroPanel
2017Zheng KC, Aoki K, Li XQ, Lin SG, Wu BS, Zhong WL, Chen TH, Lin S, You JW, Su CSerum Pepsinogens, Gastrin-17 and Helicobacter pylori Antibody in the Residents of Two Cities with District Mortality Rates of Gastric Cancer. Tohoku J Exp Me 2012; 228(4):289-294.GastroPanel
2017Vasilyev S, Smirnova E, Popov D, Semenov A, Eklund C, Hendolin P, Paloheimo L, Syrjänen K. A New-Generation Fecal Immunochemical Test (FIT) is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia among Colonoscopy Referral Patients. Anticancer Res 2015; 35:2873-2880.ColonView
2017Syrjänen K.Serological Biomarker Panel (GastroPanel®): A Test for Non-Invasive Diagnosis of Dyspeptic Symptoms and for Comprehensive Detection of Helicobacter pylori Infection. Biomark J. 2017, 3:1. DOI: 10.21767/2472-1646.100024.GastroPanel
2017Kokkola A, Sipponen P, Rautelin H, Härkönen M, Kosunen TU, Haapiainen R, Puolakkainen P. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002; 16:515-520.Gastric disease
2017Aresvuo Ulla Tupakanvierotusmenetelmät, niiden teho, haitta- vaikutukset ja vasta-aiheet, Metropolia Ammattikoulu. Insinööri (AMK). Bio- ja elintarviketekniikka, Insinöörityö. 5.5.2017Smoking cessation
2017Salaspuro V, Hietala J, Kaihovaara P, Pihlajarinne L, Marvola M, Salaspuro M.Removal of acetaldehyde from saliva by a slow release buccal tablet of L-cysteine. Int J Cancer 2002; 97:361-364.Acetaldehyde
2017Sebastian S, McLouglin R, Hall W, Qasim A, O`Connor H, Buckley M, O`Morain CNon-Invasive Methods of Diagnosis of Gastric Intestinal Metaplasia – an Observational Case-Control Study. Gastroenterol 2003; 124 (4)(Suppl 1): A-423 (M2142).GastroPanel
2017Sebastian S, Hall W, Qasim A, McLoughlin R, O`Connor H, Crotty P, Buckley M, O`Morain C Jr.Detection of Premalignant Lesions in First Degree Relatives of Gastric Cancer: Endoscopy or Serodiagnosis? Gastroenterol 2003; 124 (4)(Suppl 1): A-420 (M2126).GastroPanel
2004Salonen E-M, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H.CAntinuclear Antibody Assays in 430 Patients with SLE and Other Rheumatic Diseases (Extended report). Ann Rheum Dis 2004; 63: 1250-1254. Anti-telomere antibodies
2012Noah Noah D, Okomo Assoumou MC, Bagnaka SAFE, Ngaba GP, Alonge IE, Paloheimo L, Njoya O. Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection. Open Journal of Gastroenterology 2012; 2:113-118.GastroPanel
2015Reshetnikov OV, Kurilovich S, Molchanova A.Association of H.pylori with pepsinogen II level. Helicobacter 2010; 15(4):371.GastroPanel
2010Veijola LI, Oksanen AM, Sipponen PI, Rautelin HIK Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.World J Gastroenterol 2010 16(1): 83-88.Gastric disease
2015Venerito M, Radünz M, Reschke K, Reinhold D, Frauenschläger K, Jechorek D, Di Mario F, Malfertheiner P. Autoimmune gastritis in autoimmune thyroid disease. Aliment Pharmacol Ther 2015; 41: 686–693. Aliment Pharmacol Ther. 2015 Feb 3. doi: 10.1111/apt.13097.GastroPanel
2012Rugge M, Fassan M, Pizzi M, Zorzetto V, Maddalo G, Realdon S, De Bernard M, Betterle C, Cappellesso R, Pennelli G, de Boni M, Farinati F. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther. 2012 Jun;35(12):1460-6. doi: 10.1111/j.1365-2036.2012.05101.x. Epub 2012 Apr 22.Pepsinogen I monoclonal antibody
2015Sipponen P and Maaroos HIChronic gastritis. Scand J Gastroenterol 2015; 50:657-667.Gastric disease
2010Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis 2010; 29(7):907-11.GastroPanel
2016Di Mario F, Landi S, Grillo S, Corrente V, Franceschi M, Cannizzaro R, Baldassarre F, Grande G, Rugge M.PPI-test for diagnosis of body atrhopic gastritis: a prospective study. Helicobacter 2016; 21(Suppl 1):128-129 (P06.05)Gastric disease
2016Franceschi M, Panozzo M, Ferronato A, Antico A, Tomba F, Di Mario F, Cerofolini A, Morini A, Visona A, Gasparri L, Baldassarre G.Time trends in histological and serological prevalence of Helicobacter pylori infection: focus on a dyspeptic population in a North-East Italy area. Helicobacter 2016; 21(Suppl 1):104 (P02.06)Pepsinogen I PPI
2016Syrjänen K, Salminen J, Aresvuo U, Hendolin P, Paloheimo L, Eklund C, Salaspuro M, Suovaniemi O.Elimination of Cigarette Smoke-derived Acetaldehyde in Saliva by Slow-release L-Cysteine Lozenge Is a Potential New Method to Assist Smoking Cessation. A Randomised, Double-blind, Placebo-controlled Intervention. Anticancer Res 2016; 36: 2297-2306.Acetium
2016Kari Syrjänen A Panel of Serum Biomarkers (GastroPanel®) in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis. Anticancer Res 2016; 35(10):5133-5144.Gastropanel
2016Vohlonen I, Pukkala E, Malila N, Härkönen M, Hakama M, Koistinen V, Sipponen PRisk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up. Scand J Gastroenterol 2016; 51(10):1159-1164.Helicobacter
2010Linderborg K, Marvola T, Marvola M, Salaspuro M Färkkilä M and Väkeväinen SReducing Carcinogenic Acetaldehyde Exposure in the Achlorhydric Stomach With Cysteine. Alcohol Clin Exp Res 2010; 35(3):516-522.Acetaldehyde
2004Salonen E-M, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere Antibodies in Systemic Lupus Erythematosus (SLE): A Comparison with Five Antinuclear Antibody Assays in 430 Patients with SLE and Other Rheumatic Diseases (Extended report). Ann Rheum Dis 2004; 63: 1250-1254.Anti-telomere antibodies
2011Gatta L, Di Mario F, Vaira D, Rugge M, Franzè A, Plebani M, Cavestro GM, Lucarini P, Lera M, Scarpignato C. Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Helicobacter pylori. Clin Gastroenterol Hepatol. 2011; 9(5):440-442.GastroPanel
2011He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y. Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs.J Gastroenterol Hepatol. 2011; 26(6):1039-46Pepsinogen II
2016Aine R, Kahar E, Aitokari K, Salminen J, Eklund C, Paloheimo L, Peetsalu A, Syrjänen K. Atrophic gastritis (AG) and its clinical sequels among elderly people in Finland and Estonia. A comparative study using GastroPanel and B12- vitamin testing of the residents in assisted-housing facilities. J Aging Res Clin Practice 2016;5(4):194-202.GastroPanel
2010Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R, Torchio B.Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med 2010; 48(9):1327-32GastroPanel
2004Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB Mernova VP. The non-invasive diagnosis of precancerous changes of stomach mucosa . Annales Academiae Medicae Bialostocensis, Roczniki Akademii Medycznej w Bialymstoku 2004; 49:66-71.GastroPanel
2009van Marrewijk CJ, van Oijen MG, Paloheimo LI, Fransen GA, Mujakovic S, Muris JW, Numans ME, de Wit NJ, Grobbee DE, Knottnerus JA, Laheij RJF, Jansen JB. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Aliment Pharmacol Ther. 2009; 30(1):82-9.GastroPanel
2011Koumi A, Filippidis T, Leontara V, Makri L, Panos MZDetection of Helicobacter pylori: A faster urease test can save resources. World J Gastroenterol. 2011 Jan 21;17(3):349-53.Helicobacter pylori Quick Test
2014Kayamba V, Chomba M, Kelly P. Short term micronutrient-antioxidantsupplementation has no impact on a serological marker of gastric atrophy in Zambian adults:retrospective analysis of a randomised controlled trial. BMC Gastroenterol 2014; 14:52.Pepsinogens
2015Gou Y, Wang W, Jin A, Chen H, He W, Huang X. Diagnostic Values of Serum Pepsinogens, Gastrin 17 and Helicobacter pylori IgG Antibodies for Atrophic Gastric or Gastric Cancer Patients Screening in a high risk area in China. UEGW 2015. Poster presentation P1790.GastroPanel
2010Pimanov SI, Makarenko EV, Ruselik EV. H.pylori eradication improves serological diagnosis of atrophic gastritis in patients with duodenal ulcer. Helicobacter 2010;15(4):354.GastroPanel
2006Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12(44):7172-7178GastroPanel
2015Di Mario F, Goni E, Franceschi M, Baldassarre G, Cannizzaro R, Dal Bo N, Corrente V, Bertelè A, Venerito M, Malfertheiner P, Scarpignato C, Rugge M. DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS. UEGW 2015 Poster presentation P1095.GastroPanel
2005Di Mario F, Ingegnoli A, Altavilla N, Cavallaro LG, Bertoloni S, Merli R, Cavestro GM, Iori V, MAino M, Leandro G, Franzé A. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundamental & Clinical Pharmacology 2005: 19;497-501. GastroPanel
2009Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol. 2009; 44(5):564-70.GastroPanel
2005Nurgalieva Z.Z, El-Zimaity H.M, Graham D.Y, Campos A, Guerrero L, Chavez A, Opekun A.R, Cardenas V. Gastric in North America: Histology Vs. Non-Invase Testing. Gastroenterology 2005; 128 (4, Suppl 2): A-291GastroPanel
2017Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther 2017;46:657-667, doi: 10.1111/apGastroPanel
2017Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue Jr. TM, Kharbanda K, Cruz M, Opris M.Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp Mol Pathol 2017;102(1):168-180.Gastric disease
2009AH Poulsen, S Christensen, JK McLaughlin, RW Thomsen, HT Sørensen, JH Olsen and S FriisProton pump inhibitors and risk of gastric cancer: a population-based cohort study. British Journal of Cancer 2009; 100:1503–1507.Gastric disease PPI
2006Sipponen PBiomarkers in Clinical practice: a tool to find subjects at high risk fro stomach cancer. A personal view. Advances in Medical Sciences 2006;51;51-53GastroPanel
2016Vohlonen I, Härkönen M, Malila N, Pukkala E, Sipponen P, Koistinen K, Hakama M. Challenges in evaluation of screening for gastric cancer among men based on nonrandomized design , Acta Oncologica 2017. DOI:10.1080/0284186X.2016.1278304GastroPanel
2007Ojetti V, La Mura R, Zocco MA, Cesaro P, De Masi E, La Mazza A, Cammarota G, Gasbarrini G, Gasbarrini A. Quick test: a new test for the diagnosis of duodenal hypolactasia. Dig Dis Sci. 2008 Jun;53(6):1589-92.Lactose Intolerance
2007van Oijen MGH, Sipponen P, Laheij RJF, Verheugt FWA, Jansen JBMJ. Gastric status and vitamin B12 levels in cardiovascular patients. Dig Dis Sci 2007; 52(9):2186-2189.GastroPanel
2016Sipponen P, Maaroos HI. Krooniline gastriit (in Estonian). Eesti Arst 2016;95(10):637-643.Atrophic gastritis
2014Di Mario F, Goni E. Misleading results in the diagnosis of atrophic gastritis. Eur J GastroenterolHepatol 2014, Vol 26 No 12GastroPanel
2006Sun LP, Gong YH, Wang L, Gong W, Yuan Y. Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county. Zhonghua Yi Xue Za Zhi. 2006 Oct 31;86(40):2826-30. [Article in Chinese].GastroPanel
2015Venerito M, Varbanova M, Röhl F, Reinhold D, Frauenschläger K, Weight J, Link A, Malfertheiner P. Oxyntic gastric atrophy in autoimmune gastritis compared to Helicobacter pylori gastritis. Poster presentation P01.17 at European Helicobacter Study Group 2015 congress. Helicobacter 2015:20(Suppl. 1); 90.GastroPanel
2007Zhang Z, Sun LP, Gong YH, Wang XG, Zhang M, Yuan YFactors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese. J Dig Dis 2007; 8:72-76.GastroPanel
2014Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja MGastric cancer: Prevention, screening and early diagnosis World J Gastroenterol 2014; 20(38):13842-62.GastroPanel
2005Germana B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel B, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franz´e A. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 2005; 37:501–508.GastroPanel
2013Leja M, Funka K, Janciauskas D, Putnins V, Ruskule A, Kikuste I, Kojalo U, Tolmanis I, Misins J, Purmalis K, Pimanov S, Makarenko J, Kupcinskas L, Vikmanis U. Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol 2013; 25(6):694-699. doi: 10.1097/MEG.0b013e32835e3397.Gastric disease
2016Syrjänen, K. Caveats in Diagnosis of Helicobacter Pylori Infection can be Avoided by a Panel of Serum Biomarkers (GastroPanel®). Carcinog Mutagen 2016; 7(6):1-3.GastroPanel, Helicobacter
2010Song HJ, Jang SJ, Yun SC, Park YS, Kim MJ, Lee SM, Choi KD, Lee GH, Jung HY, Kim JHLow Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy. Gut Liver 2010; 4(4):475-80.GastroPanel
2016Hellström PM, Hendolin P, Kaihovaara P, Kronberg L, Meierjohann A, Millerhovf A, Paloheimo L, Sundelin H, Syrjänen K, Webb D-L, Salaspuro MSlow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis. Scand J Gastroenterol 2017; 52 (2):230-237.Acetaldehyde Acetium
2016Kotelevets SM, Galeeva ZM, Karakotova ZB, Chekh SANovel information on the genetic factors involved in the development of diseases. Eur Rev Med Pharmacol Sci 2016; 20 (17): 3672-3678GastroPanel
2016Salaspuro M.Elintarvikkeiden ja alkoholijuomien turvallisuutta valvovien viranomaisten uskottavuus horjuu. Kirjeitä ja mielipiteitä. Duodecim 2016;132:2363–4.Acetaldehyde
2005Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Varvara P. Mernova VP, Polyakova MB.Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: A comparative study. Scand J Gastroenterol, 2005; 40: 297-301.GastroPanel
2016Ricanek P, Vatn S, Lindahl T, Ciemniejewska E, Jahnsen J, Casen C, Vatn MHMicrobiota profiles in treatment-naïve Norwegian IBD and non-IBD patients: part of the European Union IBD character consortium. Congress presentation DOP089 at ECCO 2016 in Amsterdam, the Netherlands.Microbiota
2011Novikova VP, Sidorkin AO, Anichkov NM, Azanchevskaia SV. Morpho-functional peculiarities of autoimmune gastritis in different age groups. Eksp Klin Gastroenterol. 2011;(5):26-30. [Article in Russian].GastroPanel
2014Tursi A, Grattagliano I, De Polo M, Pirrotta E, Bacchin P, Picchio M, De Bastiani R. Noninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care. Scand J Gastroenterol. 2014; 49(11):1394-1396.Gastric disease
2013Adamczyk M , Peczek ?, Rudnicki C, Nawrot B, Stec-Michalska K. Pol Merkur Lekarski.Pol Merkur Lekarski. The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer. Pol Merkur Lekarski 2013; 35(207):141-147. [ArticleGastroPanel
2012Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, Sung J. Rationale in diagnosis and screening of atrophic gastritis with stomach specific plasma biomarkers. Scand J Gastroenterol 2012; 47:136-147.GastroPanel
2015Di Mario F, Goni E, Dal Bo N, Ferrara F, Marcello R, Grande G, Franceschi M, Ricco M, Scarpignato C, Rugge M. RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM_ ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS. W5.6 Presentation at European Helicobacter Study Group 2015 congress. Helicobacter 2015: 20(Suppl.1);83Acetium GastroPanel
2015Goni E, Franceschi M, Scarpignato C, Rugge M, Di Mario F.RELATIONSHIP BETWEEN GASTROPANEL AND O.L.G.A IN THE DETECTION OF CHRONIC ATROPHIC GASTRITIS IN A PRIMARY CARE SETTING. UEGW 2015 Poster presentation P0514.GastroPanel
2015McNicholl AG, Valle J, Gisbert JP. Response to: Accuracy of GastroPanel test in detection of atrophic gastritis. Eur J Gastroenterol Hepatol 2015; 27:105-106.GastroPanel
2010Pomytkina TEResults of evaluating the functional state of the gastric mucosa in duodenal peptic ulcer by means of a test GastroPanel in workers engaged in the manufacture of nitrogen compounds. Ter Arkh. 2010; 82(2):17-20. [Article in Russian].GastroPanel
2015McNicholl AG, Gisbert JP. Response to: Misleading results in the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2015, 27:104.GastroPanel
2008Maev IV, Mel'nikova EV, Kashin SV, Nadezhin AS, Kriukova TV. Serologic screening for preneoplastic pathology and early stomach cancer. Klin Med (Mosk). 2008;86(11):43-8. [Article in Russian].GastroPanel
2015Kotelevets SM, Chekh SA. Serological Criteria for Mild, Moderate and Severe Atrophy in Atrophic Gastritis. Biol Med 2015; 7: 235GastroPanel
2012Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H.Serum pepsinogen test for early detection of gastric cancer in a European Country. Eur J Gastroenterol Hepatol 2012; 24(1):37-41.GastroPanel
2009Kamangar F, Diaw L, Wei WQ, Abnet CC, Wang GQ, Roth MJ, Liu B, Lu N, Giffen C, Qiao YL, Dawsey SM. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 2009: 124(2);456-60.GastroPanel
2004Salaspuro V, Salaspuro M. Synergistic effect of alcohol drinking and smokingon in vivo acetaldehyde concentration in saliva. Int J Cancer 2004; 111:480-483.Acetaldehyde
2014Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Long Q, Flanders WD, Bostick RM, Yuan Y. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer. 2015 Jan 15;136(2):425-34.GastroPanel
2004Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB Mernova VP. The non-invasive diagnosis of precancerous changes of stomach mucosa . Annales Academiae Medicae Bialostocensis, Roczniki Akademii Medycznej w Bialymstoku 2004; 49:66-71. GastroPanel
2013George DA, Hui LL, Rattehalli D, Lovatt T, Perry I, Green M, Robinson K, Walters JRF, Brookes MJ. The role of near-patient coeliac serology testing in the follow-up of patients with coeliac disease. Fl Gastro Sept 2013 online doi:10.1136/flgastro-2013-100342Celiac Disease
2010Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver 2010;4:307-19.Pepsinogen
2009Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kiudelis G, Chiu H-M, Lin J-T. The Validity of a Biomarker Method for Indirect Detectionof Gastric Mucosal Atrophy Versus Standard Histopathology. Dig Dis Sci 2009; 54(11):2377-84.GastroPanel
2014Zhang XM, Li JX, Zhang GY, Li XH, Gu H.The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterology 2014, 14:3 (doi:10.1186/1471-230X-14-3)Gastric disease
2007de Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, Bizzarri B, Merli R, Comparato G, Caruana P, Cavestro GM, Franzé A, Di Mario F. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Dig Dis. 2007;25(3):206-13.GastroPanel
2005Di Mario F, Cavallaro LC, Moussa AM, Caruana P, Merli R, Maini A, Bertolini S, Dal B´o N, Rugge M, Cavestro GM, Aragona G, Plebani M, Franz´e A, Nervi G. Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: RelationshipWith Inflammation, Activity, and Density of the Bacterium. Dig Dis Sci 2006; 51:1791–1795.GastroPanel
2011Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas AValue of gastrin-17 in detecting antral atrophy. Advances in Medical Sciences 2011; 56:145-150.GastroPanel
2017Syrjänen K, Eronen K, Hendolin P, Paloheimo L, Eklund C, Bäckström A, Suovaniemi O. Slow-Release L-Cysteine (Acetium®) Lozenge is an Effective New Method in Smoking Cessation. A randomised, double-blind, placebo-controlled intervention. AntiCancer Research 2017;37:3639-3648.Acetaldehyde
2017Di Mario F, Ferrara F, Dal Bò N, Slongo T, Caroli A, Guarnieri G, Marcello R, Heras Salvat H, Loperfido S, Savarino V, Scarpignato C.A New Approach to Detection of Non-Responder Patients in GERD by Non-Invasive Markers. Gastroenterology 2013;144 (5): S-856 (Tu1825). DDW 2013 poster abstract; Tu1825 (A-1398).GastroPanel
2008German SV. About early preclinical diagnosis of gastroduodenal pathology upon exposure to environmental factors. Gig Sanit. 2008 Nov-Dec;(6):61-4. [Article in Russian].GastroPanel
2017McNicholl AG, Ducons J, Barrio J, Bujanda L, Forné-Bardera M, Aparcero R, Ponce J, Rivera R, Dedeu-Cuso JM, Garcia-Inglesias P, Montoro M, Bejerano A, Ber-Nieto Y, Madrigal B, Zapata E, Loras-Alastruey C, Castro M, Nevarez A, Mendez I, Bory-Ros F, MiquelAccuracy of Ultra-Rapid Urease Test for the diagnosis of H. pylori infection. Helicobacter 2010; 15(4):360Helicobacter
2017Di Mario F. Diagnostic accuracy of serum pepsinogens and gastrin to follow-up H.pylori infection. Helicobacter 2010;15(4):350GastroPanel
2017Vriezinga S, Van de Geest B, van Roessel K, Boers A, Putter H, Rings E, Wahab R, Mearin L. Accuracy of three commercially available point-of-care tests in monitoring celiac disease, Espghan 2016 lecture presentation. no internet connectionCeliac disease
2015Mooney PD,  Wong SH,  Johnston AJ,  Kurien M,.Avgerinos A, Sanders DS. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy Clinical Gastroenterology and Hepatology 2015;13:1278–1284.Celiac disease
2011Leja M, Upmace I, Park JY, Plummer M, Herrero R. MULTICENTRIC RANDOMIZED STUDY OF H.PYLORI ERADICATION AND PEPSINOGEN TESTING FOR PREVENTION OF GASTRIC CANCER MORTALITY (GISTAR). THE STUDY DESIGN. UEG J 2013; 1 (Suppl 1):A4 (OP016).GastroPanel
2005Di Mario F, Moussa AM, Dal Bo N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Merli R, Franzé A, Rugge M . Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study. J Gastroenterol Hepatol 2005: 20;1661-1666.GastroPanel
2017Charlier-Bret N, Boucher B, Ly TD, Soussy CJ, Zerbib F, Duran Cordobes M, Fromage M, Poisson F, Vaugelade C, Courillon Mallet A, De Korwin JD, Fauchère JL, Mégraud F, Raumind J, Delchier JC (AFSSAPS)HELICOBACTER PYLORI IGG – ÉVALUATION COMPARATIVE DE 29 DISPOSITIFS MÉDICAUX DE DIAGNOSTIC IN VITRO (DMDIV) DISPONIBLES EN FRANCE EN 2008. RICAI 2009, Paris, France. http://www.ricai.fr/archives/2009/ 25/StreptocoquesHelicobacter
2012Kartal-Hodzic Alma. Formulation studies for eliminating saliva carcinogenic acetaldehyde with L-cysteine containing chewing gum. Ph.D. Dissertation, University of Helsinki, 2012Acetaldehyde
2017Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y.A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017;112(5):704-715.GastroPanel
2017Shan JH, Bai XJ, Han LL, Yuan Y, Sun XF Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population. Worls J Gastroenterol 2017; 23(32):5945-5953. doi: 10.3748/wjg.v23.i32.5945.GastroPanel
2017Syrjänen K.Subjects with Compromised Stomach Health Need Special Attention: Serological Biomarker Panel (GastroPanel®) for Monitoring and Slow-Release L-Cysteine (Acetium® Capsule) for Protection of the Stomach”. EC Gastroenterology and Digestive System 2017; 4.3: 7GastroPanel
2017Syrjänen K.Serum Biomarker Panel (GastroPanel®) and Slow-Release L-cysteine (Acetium® Capsule): Rational for the Primary Prevention of Gastric Cancer. EC Gastroenterology and Digestive System 2017; 3.6: 172-192.GastroPanel, Acetium
2018Nieminen MT, Salaspuro M.Local Acetaldehyde - An Essential Role in Alcohol-Related Upper Gastrointestinal Tract Carcinogenesis. Cancers 2018, 10, 11; doi:10.3390/cancers10010011Acetaldehyde
2018Ebule IA, Djune FAK, Njeambosay BA, Doh GN, Metaghue G, Majuikouo L, Befolo MHDM, Nkayo M, Tanni B, Heugueu C, FEUATSAPK C, Noah ND, Paloheimo L and Syrjänen K.Association of Helicobacter Pylori Infection and Diabetes Mellitus Type 2 Subjects in Yaounde Cameroon Using a Panel of Serum Biomarkers (PGII, HpIgG): A Case Control Study. J Clin Gastroenterol Treat 2017, 3:053. DOI: 10.23937/2469-584X/1510053GastroPanel
2017Suumann J, Sillakivi T, Riispere Ž, Syrjänen K, Sipponen P, Kirsimägi Ü, Peetsalu A.Serological biomarker testing helps avoiding unnecessary endoscopies in obese patients before bariatric surgery. BMC Obesity 2018; 5:1-9. https://doi.org/10.1186/s40608-018-0185-5.GastroPanel
2018Prof. Bojan Tepes, M.D., Ph.D., FEBGH FSMA, Maja Seruga, Miroslav Vujasinovic, Dejan Urlep, Liljana Ljepovic, Jurecic Nataša Brglez, Alenka Forte, Ljubec Anita Kek, Miha SkvarcPremalignant Gastric Lesions in Patients Included in National Colorectal Cancer ScreeningGastroPanel, Helicobacter
2018Flanagan AM, Kelly L, McGee C, Ward S, Paloheimo L, Richardson C, McConnell RI, Lamont JV, FitzGerald SPDevelopment of a biochip array for the rapid, simultaneous detection of Pepsinogen I, Pepsinogen II and Gastrin 17, on the new random access, fully automated Evidence Evolution analyser. Abstract in 70th AACC Annual Scientific Meeting, 2018, pS255 (B-377)GastroPanel
2018Skrebinska S, Daugule I, Santare D, Isajevs S, Liepniece-Karele I, Rudzite D, Kikuste I, Vanags A, Tolmanis I, Atstupens J, Park JY, Herrero R, Leja M. Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H.pylori in middle-aged Caucasian general population sample. Scand J Gastroenterol 2018; 53 (7):777-783.Helicobacter
2018den Hollander WJ, I Lisanne Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten M-P, Prytz-Berset I, Witteman EM, ter Borg F, den Hartog G, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCWSurveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions, Gut 2018;0:1–9. doi:10.1136/gutjnl-2017-314498 GastroPanel
2006Suovaniemi O.GastroPanel dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen Erillispainos Yksityislääkäri-lehti 5/06GastroPanel
2019Khitam Muhsen, Ronit Sinnreich, Dafna Merom, Gany Beer-Davidson, Hisham Nassar, Dani Cohen, Jeremy D KarkPrevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional studyGastroPanel
2017Syrjänen, K. Role of Serological Biomarker Testing (GastroPanel®) in Diagnosis of Symptomatic Dyspepsia and in Screening of the Risks of Stomach Cancer. EC Gastroenterology and Digestive System 2017; 1.6: 209-222.Gastropanel
2017Slăvescu KC, Pirvan A, Gheban D, Eklund C, Hendolin P, Paloheimo L, Syrjänen K.A point-of-care test for anti-transglutaminase (tTG2A) IgA, IgG, IgM antibodies (CELIAC Quick Test®) validated in diagnosis of incident celiac disease (CD) in pediatric patients. EC Gastroenterology and Digestive System 2017; 3 (1): 04-13.Celiac disease
2017Syrjänen K, Eronen K, Hendolin P, Paloheimo L, Eklund C, Bäckström A, Suovaniemi O. Slow-Release L-Cysteine (Acetium®) Lozenge is an Effective New Method in Smoking Cessation. A randomised, double-blind, placebo-controlled intervention. AntiCancer Research 2017;37:3639-3648.Acetaldehyde
2016Roman LD, Lukyanchok R, Sablin OA , Araslanova EI, Eklund C, Hendolin P, Paloheimo L, Syrjänen K. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel ®) in St. Petersburg. Anticancer Res 2016; 36:4129-4138.GastroPanel
2016Kurilovich S, Belkovets A, Reshetnikov O, Openko T, Malyutina S, Ragino Y, Scherbakova L, Leja M, Paloheimo L, Syrjänen K, Voevoda M. Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia. Anticancer Res 2016; 36(1):247-53.GastroPanel
2013Benberin V, Bektayeva R, Karabayeva R, Lebedev A, Akemeyeva K, Paloheimo L, Syrjänen K.Prevalence of H. pylori Infection and Atrophic Gastritis Among Symptomatic and Dyspeptic Adults in Kazakhstan. A Hospital based Screening Study Using a Panel of Serum Biomarkers. ANTICANCER RESEARCH 2013; 33: 4595-4602.Helicobacter
2016Syrjänen K, Eronen K. Serological Testing in Management of Dyspeptic Patients and in Screening of Gastric Cancer Risks. J Gastrointest Disord Liver Func 2016GastroPanel
2018Quancai Cai,et al.Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre studyGastroPanel